MAKING OBJECTIVE DRUG EVIDENCE REVISIONS FOR NEW LABELING ACT OF 2020

Publisher: U.S. Government Publishing Office
Coverage: 1v. Washington: U.S. G.P.O., 2020

Volumes:

H. Rept. 116-573 (2020-11-16)